cardiovascular disease

Pop Quiz: FIDELIO-DKD Trial

AUTHOR:
James Matera, DO
Practicing Nephrologist, Senior Vice President for Medical Affairs, and Chief Medical Officer
CentraState Medical Center, Freehold, New Jersey

In 2021, the results of the finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD) trial were published. Finerenone is a selective, mineralocorticoid antagonist with positive impacts on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD).¹ Finerenone was added to supplement standard therapy with renin-angiotensin-aldosterone system inhibitor (RAASi) agents. FIDELIO-DKD trial investigators examined finerenone’s impact on cardiovascular outcomes in patients with and without history of atherosclerotic cardiovascular disease.²

References:

Bakris GL, Agarwal R, Anker SD, et al; FIDELIO-DKD Investigators. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219-2229. https://doi.org/10.1056/nejmoa2025845
Filippatos G, Anker SD, Agarwal R, et all; FIDELIO-DKD Investigators. Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes. Circulation. 2021;143(6):540-552. https://doi.org/10.1161/circulationaha.120.051898

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Conference Coverage

Conference Coverage

Preview: Perspectives on Virtual Care in Primary Care

11/05/2024

Joseph Kvedar, MD

Dr Kvedar provides a preview of his session, "Perspectives on Virtual Care in Primary Care" at PUPC 2024. In this session, Dr Kvedar will review the modalities for providing virtual care, some friction...

11/05/2024

Research Summary

Does Inflammatory Bowel Disease Increase the Risk of Chronic Respiratory Diseases?

11/03/2024

Miranda Manier, BA

A prospective study reveals that individuals with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn disease have a significantly higher risk of developing chronic obstructive pulmonary disease...

11/03/2024

COVID-19 ROUNDUP

Elevated Risks for Patients Hospitalized With COVID-19 at 3 Years, Worldwide Overuse of Antibiotics, Perinatal Health Among Birth Mothers With SARS-CoV-2 Infection, and More

10/28/2024

Anthony Calabro, MA

In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...

10/28/2024

Research Summary

Research Summary

Virtual Reality as a Nonpharmacologic Therapy for Pain in Patients With Cancer

10/28/2024

Miranda Manier, BA

In a prospective randomized controlled trial, researchers evaluated the effectiveness of virtual reality as a nonpharmacologic therapy for pain in hospitalized patients with cancer.

10/28/2024

Research Summary

Research Summary

Can Maintaining Immunosuppressants Reduce Relapse Rates for Patients With Stable Immunoglobulin G4-Related Disease?

10/28/2024

Miranda Manier, BA

A multicenter, randomized controlled trial revealed that continuing immunosuppressants, with or without low-dose glucocorticoids, reduces relapse rates for patients with stable IgG4-related disease compared...

10/28/2024

Trending Articles

Pop Quiz

What Do You Know About Endometrial Cancer?

10/16/2024

The risk for endometrial cancer increases as women get older. Which of the following is NOT a risk factor for endometrial cancer?A. Overweight and obesityB. Family historyC. Having multiple childrenD....

10/16/2024

Roundtable

Roundtable

Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring

09/25/2024

In this video, Naim Alkhouri MD, FAASLD, moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC, and Mazen Noureddin, MD, MHSc, on the practical clinical applications associated with...

09/25/2024

ROUNDTABLE

ROUNDTABLE

Key Updates on the Treatment and Management of MASH

10/08/2024

In this video, James Matera, DO, moderates a roundtable discussion with Colin Browm, MD, Kunal Gupta MD, and Lisa Jones, MA, RDN, LDN, FAND, on recent developments regarding the treatment and management...

10/08/2024